BiotechTubeBiotechTube
Home/Inovio Pharmaceuticals/Michael Sumner, MB BS, MBA
MS

Michael Sumner, MB BS, MBA

Chief Medical Officer & Head of Development

Inovio Pharmaceuticals

Therapeutic Areas

HPV-related DiseasesOncologyInfectious Diseases

Inovio Pharmaceuticals Pipeline

DrugIndicationPhase
INO-3107Recurrent Respiratory Papillomatosis (RRP)BLA Submitted
VGX-3100HIV-Positive High-Grade Anal LesionsPhase 2
INO-5401Cancer Prevention in BRCA1/2 Mutation CarriersPhase 1
DMAb-1Prevention of COVID-19Phase 1
DMAb-2Prevention of COVID-19Phase 1

Leadership Team at Inovio Pharmaceuticals

JS
Jacqueline Shea, Ph.D.
President & Chief Executive Officer
PK
Peter Kies
Chief Financial Officer
LH
Laurent Humeau, Ph.D.
Chief Scientific Officer; Chairman, Scientific Advisory Board
SE
Steve Egge, MBA
Chief Commercial Officer
RC
Rob Crotty, J.D.
General Counsel, Corporate Secretary & Chief Compliance Officer
EB
EJ Brandreth, MBA
Senior Vice President, Quality Assurance
SB
Shawn Bridy, MA, MBA
Senior Vice President, Business Development
CE
Cheryl Elder, PharmD
Senior Vice President, Regulatory Affairs
RJ
Robert J. Juba Jr.
Senior Vice President, Biological Manufacturing and Clinical Supply Management
JS
Jeffrey Skolnik, M.D.
Senior Vice President, Clinical Development
View full Inovio Pharmaceuticals profile